Per the FDA's request, HHS is updating hormone therapy labels, removing misleading warnings to empower women in managing ...

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about ...

Hormone-based treatments for menopause symptoms will no longer have a bold warning label about serious risks such as stroke, heart attack and dementia.

A 12 mg dose of BPL-003 (mebufotenin benzoate nasal spray) administered eight weeks after an initial 12 mg, 8 mg or 0.3 mg ...

The US FDA is removing serious health warnings from hormone replacement therapies. Scientists worry that more work is needed ...

Food labels can be confusing for the average consumer. Some phrases can be misleading, while others are listed for food ...

The decision, issued without the input of an official advisory committee, revises long-held labeling on the drugs cautioning ...

In a pivotal move, the US Food and Drug Administration has changed // done away with the lengthy black box warning on many hormone treatments for women with menopause symptoms.

Black box labels on the medications — which are prescribed to treat menopause symptoms — warn of serious risks like breast ...

The Food and Drug Administration (FDA) announced Monday that it will remove black box warning labels from hormone replacement ...

A weekend gathering in Texas drew activists, homeopaths, doctors, lawyers, parents and a Republican senator who asked, “Why ...

Much to the delight of ob-gyns long espousing the upsides of hormone therapy (a.k.a. hormone replacement therapy, or HRT) for ...